Head DCT Strategy & Implementation
Angela has 20 years of experience in clinical research, primarily with a pharmaceutical company. She has a strong operational background with significant experience in various roles in study and program management including large phase 3 outcome trials. In her current role Angela leads a group with specialist operational expertise in designing and implementing DCT in interventional clinical trials, including hybrid and fully-remote approaches. She and her team are also working to help develop broader capabilities and infrastructure to support DCT and other disruptive approaches in the future.